Chelidamic Acid

Chelidamic Acid

SCHEMBL742928

O=C(O)c1cc(=O)cc(C(=O)O)[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 1.00
BLM P54132 2/20 1.00
NFKB1 P19838 1/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
ALDH1A1 P00352 2/20 0.56
LMNA P02545 1/20 0.56
CYP2C19 P33261 3/20 0.52
TSHR P16473 2/20 0.48
GPR35 Q9HC97 3/20 0.45
HPGD P15428 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 2/20 0.45
MEN1 O00255 2/20 0.45
GRIN2D O15399 2/20 0.45
GRIN3B O60391 2/20 0.45
CYP1A2 P05177 2/20 0.45
KMT2A Q03164 2/20 0.45
GRIN1 Q05586 2/20 0.45
GRIN2A Q12879 2/20 0.45
GRIN2B Q13224 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chelidamic Acid SCHEMBL1176783 0.97 ALOX15 (0.95) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
Chelidamic Acid SCHEMBL9658074 0.97 ALOX15 (0.95) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
SCHEMBL14634236 0.85 ALOX15 (0.72) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
SCHEMBL13075694 0.80 ALOX15 (0.65) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
Chelidamic Acid SCHEMBL1535360 0.78 ALOX15 (0.60) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
SCHEMBL4264907 0.77 ALOX15 (0.61) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
SCHEMBL13872418 0.76 SMN1; SMN2 (0.61) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
Chelidamic Acid SCHEMBL4877522 0.74 ALOX15 (0.58) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
SCHEMBL70048 0.73 NFKB1 (0.57) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1
Orotic Acid SCHEMBL20865 0.72 ALDH1A1 (1.00) ALOX15BLMNFKB1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 695 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250180480-A1 DETERMINING PARTITION COEFFICIENTS OF TRACER ANALYTES SAUDI ARABIAN OIL COMPANY (SA) 2025-06-05 US claimed
US-12253467-B2 Determining partition coefficients of tracer analytes SAUDI ARABIAN OIL COMPANY (SA) 2025-03-18 US claimed
US-12096768-B2 Polymeric and solid-supported chelators for stabilization of peracid-containing compositions ECOLAB USA INC. (US) 2024-09-24 US claimed
EP-3692083-B1 NOVEL POLYMERS, METHODS FOR PREPARING SAME, AND USES THEREOF PARTICULARLY FOR METAL CAPTURE UNIV PARIS SACLAY (FR) 2024-05-29 EP claimed
EP-2841943-B1 METHOD FOR CHARACTERIZING AND/OR DETERMINING SAMPLES KEMIRA OYJ (FI) 2023-09-27 EP claimed
WO-2023129040-A2 A NEW PHOSPHOPEPTIDE ENRICHMENT MATERIAL CONTAINING MAGNETIC NANOPARTICLES AND A PRODUCTION METHOD THEREOF AKDENIZ UNIVERSITESI (TR) 2023-07-06 WO claimed
US-20230184677-A1 DETERMINING PARTITION COEFFICIENTS OF TRACER ANALYTES SAUDI ARABIAN OIL COMPANY (SA) 2023-06-15 US claimed
CN-112531288-B Flame-retardant nanofiber lithium battery diaphragm and preparation method thereof 安徽南都华拓新能源科技有限公司 2022-11-08 CN claimed
CN-114395114-A Mixed ester degradable insulating material and preparation method thereof 江苏双江能源科技股份有限公司 2022-04-26 CN claimed
CN-110565398-B Rare earth doped MOF (Metal organic framework) -based dyed fluorescent fabric and preparation method thereof 东华大学 2021-12-21 CN claimed
EP-2477596-A2 CHELATOR STABILIZED CATIONIC AMMONIUM COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME Unilever PLC (GB) 2012-07-25 EP claimed
WO-2011032851-A2 CHELATOR STABILIZED CATIONIC AMMONIUM COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME UNILEVER PLC (GB) 2011-03-24 WO claimed
US-20110065802-A1 Chelator Stabilized Cationic Ammonium Compounds and Compositions Comprising the Same CONOPCO, INC., D/B/A UNILEVER (US) 2011-03-17 US claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed
CN-101812081-A Dissimilar metal chelidamic acid coordination polymer of silver and copper and preparation method thereof UNIV NANCHANG HANGKONG 2010-08-25 CN claimed
US-4741818-A COMPLEXES LEARONAL, INC. (US) 1988-05-03 US claimed
EP-0225422-A1 Alkaline baths and methods for electrodeposition of palladium and palladium alloys LeaRonal, Inc. (US) 1987-06-16 EP claimed
US-4005145-A ISOMERIZATION OF A,B-UNSATURATED OXO COMPOUNDS TO B,G-ISOMER HOFFMANN-LA ROCHE INC. (US) 1977-01-25 US claimed
US-3966649-A Liquid detergents containing chelidamic acids and salts thereof COLGATE-PALMOLIVE COMPANY 1976-06-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12096768-B2 Polymeric and solid-supported chelators for stabilization of peracid-containing compositions SUCLG1, SOD1, PLPBP ALOX15 1389/4885BLM 4213/4885NFKB1 3659/4885
US-20110065802-A1 Chelator Stabilized Cationic Ammonium Compounds and Compositions Comprising the Same SLC7A1, AAAS, AADAT ALOX15 2859/4885BLM 1636/4885NFKB1 1313/4885
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 ALOX15 914/4885BLM 3099/4885NFKB1 4024/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA ALOX15 383/4885BLM 1845/4885NFKB1 2710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.